1 patient evaluation for Golimumab taken for the purpose of 'ankylosing spondylitis' with a perceived effectiveness rating of Moderate

1 members have decided to share their profiles only with other members of PatientsLikeMe.

Nov 11, 2018 (Started Sep 23, 2018)

  • Effectiveness
    Moderate (for ankylosing spondylitis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 100 mg Monthly
Cost: $25-49 monthly

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Golimumab